Build a lasting personal brand

Datavault AI and Wellgistics Health Create DelivMeds AI Venture with $4B Asset Value

By Advos
Datavault AI and Wellgistics Health form DelivMeds AI, a healthcare platform combining AI, blockchain, and biometrics, with expected asset value of $4 billion.

Found this article helpful?

Share it with your network and spread the knowledge!

Datavault AI and Wellgistics Health Create DelivMeds AI Venture with $4B Asset Value

Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform that integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The venture is structured through three concurrent transactions: an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. These combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.

The partnership marks a significant step in the convergence of AI and healthcare, aiming to streamline pharmacy operations, enhance patient data security through blockchain, and improve patient engagement with biometric verification. The $4 billion asset valuation underscores the potential scale of this initiative, which could reshape how healthcare services are delivered directly to consumers.

Datavault AI, headquartered in Philadelphia, PA, is known for its AI-driven data experiences and monetization of assets in the Web 3.0 environment. Its cloud-based platform spans Acoustic Sciences and Data Science divisions, with patented technologies including WiSA(R), ADIO(R), and Sumerian(R) for spatial audio, and the Information Data Exchange(R) for Digital Twins and name, image, and likeness licensing. Wellgistics Health brings expertise in pharmacy logistics and healthcare distribution, making the joint venture a formidable player in the healthcare technology space.

The DelivMeds AI platform could have broad implications for the healthcare industry by reducing costs, improving medication adherence, and enhancing patient privacy. For investors, the venture represents a high-value opportunity in the growing healthcare AI market. The partnership also highlights the increasing role of blockchain in healthcare for secure data management and smart contracts.

For more details, the full press release is available at https://ibn.fm/yIVh9. Additional updates on Datavault AI can be found in the company’s newsroom at https://ibn.fm/DVLT.

Advos

Advos

@advos